GENEVA, July 9 -- CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES filed a patent application (CN2025/144266) for “USE OF NUCB1 IN PREVENTION AND/OR TREATMENT OF AUTOIMMUNE DISEASES”. With publication no. WO/2026/145099, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/17
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....